​

Addus HomeCare (ADUS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ADUS Stock Forecast

Addus HomeCare stock forecast is as follows: an average price target of $146.20 (represents a 11.26% upside from ADUS’s last price of $131.40) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.

ADUS Price Target

The average price target for Addus HomeCare (ADUS) is $146.20 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $150.00 to $141.00. This represents a potential 11.26% upside from ADUS's last price of $131.40.

ADUS Analyst Ratings

Buy

According to 8 Wall Street analysts, Addus HomeCare's rating consensus is 'Buy'. The analyst rating breakdown for ADUS stock is 0 'Strong Buy' (0.00%), 7 'Buy' (87.50%), 0 'Hold' (0.00%), 1 'Sell' (12.50%), and 0 'Strong Sell' (0.00%).

Addus HomeCare Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 16, 2024Constantine DavidesJMP Securities$150.00$122.9522.00%14.16%
Nov 06, 2024Scott FidelStephens$145.00$124.6716.30%10.35%
Oct 10, 2024Matthew GillmorKeyBanc$150.00$127.4417.70%14.16%
Sep 23, 2024Michael WiederhornOppenheimer$145.00$131.3510.39%10.35%
Aug 08, 2024Frank MorganRBC Capital$141.00$122.2215.37%7.31%
Aug 07, 2024Michael WiederhornOppenheimer$140.00$122.2214.55%6.54%
Jun 07, 2024Michael WiederhornOppenheimer$130.00$116.0712.00%-1.07%
May 31, 2024Scott FidelStephens$128.00$111.7314.56%-2.59%
May 28, 2024Frank MorganRBC Capital$129.00$111.6115.58%-1.83%
Apr 23, 2024Andrew MokBarclays$83.00$93.14-10.89%-36.83%
Apr 01, 2024Scott FidelStephens$115.00$103.3411.28%-12.48%
Jun 29, 2022Scott FidelStephens$101.00$85.1418.63%-23.14%
May 04, 2022RBC Capital$111.00$82.3434.81%-15.53%

The latest Addus HomeCare stock forecast, released on Dec 16, 2024 by Constantine Davides from JMP Securities, set a price target of $150.00, which represents a 22.00% increase from the stock price at the time of the forecast ($122.95), and a 14.16% increase from ADUS last price ($131.40).

Addus HomeCare Price Target by Period

1M3M12M
# Anlaysts1411
Avg Price Target$150.00$147.50$132.36
Last Closing Price$131.40$131.40$131.40
Upside/Downside14.16%12.25%0.73%

In the current month, the average price target of Addus HomeCare stock is $150.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 14.16% increase as opposed to Addus HomeCare's last price of $131.40. This month's average price target is up 1.69% compared to last quarter, and up 13.33% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 16, 2024JMP SecuritiesOutperformInitialise
Oct 11, 2024StephensBuyBuyHold
Oct 11, 2024RBC CapitalUnderperformUnderperformHold
Oct 10, 2024KeyBancOverweightInitialise
Sep 23, 2024OppenheimerOutperformOutperformHold
Sep 03, 2024StephensBuyBuyHold
Sep 03, 2024RBC CapitalUnderperformUnderperformHold
Aug 08, 2024Cowen & Co.BuyBuyHold
Aug 08, 2024RBC CapitalOutperformOutperformHold
Aug 07, 2024OppenheimerOutperformOutperformHold
Aug 07, 2024StephensOverweightOverweightHold
Aug 06, 2024OppenheimerUnderperformUnderperformHold
Aug 06, 2024StephensBuyBuyHold
Jun 28, 2024MacquarieOutperformInitialise
Jun 18, 2024OppenheimerUnderperformUnderperformHold
Jun 11, 2024Cowen & Co.BuyBuyHold
Jun 07, 2024OppenheimerOutperformOutperformHold
May 31, 2024StephensBuyBuyHold
May 31, 2024StephensOverweightOverweightHold
May 28, 2024RBC CapitalOutperformOutperformHold
May 09, 2024Cowen & Co.BuyBuyHold
May 07, 2024Bank of America SecuritiesBuyBuyHold
Apr 23, 2024OppenheimerUnderperformUnderperformHold
Apr 23, 2024RBC CapitalEqual-WeightEqual-WeightHold
Apr 23, 2024BarclaysUnderweightDowngrade
Apr 01, 2024StephensOverweightOverweightHold
Mar 26, 2024RBC CapitalEqual-WeightEqual-WeightHold
Mar 26, 2024OppenheimerUnderperformUnderperformHold
Jan 17, 2024StephensOutperformOutperformHold
Jun 29, 2022StephensOverweightOverweightHold

Addus HomeCare's last stock rating was published by JMP Securities on Dec 16, 2024. The company Initialise its ADUS rating from "null" to "Outperform".

Addus HomeCare Financial Forecast

Addus HomeCare Revenue Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Revenue------------$276.35M$270.72M$259.98M$251.60M$247.05M$240.50M$236.94M$226.63M$224.64M$216.66M$217.89M$205.30M$196.00M$193.99M$184.58M$190.22M$190.04M$169.80M
Avg Forecast$382.79M$380.28M$374.51M$366.49M$348.28M$355.03M$351.04M$343.99M$284.28M$289.46M$284.90M$279.49M$274.47M$267.15M$256.31M$250.05M$246.14M$242.20M$238.48M$227.40M$226.21M$226.34M$216.79M$209.78M$197.71M$189.16M$172.12M$177.94M$182.91M$159.89M
High Forecast$394.29M$391.70M$385.76M$377.50M$358.74M$365.69M$361.58M$354.32M$295.49M$289.54M$284.90M$279.49M$276.73M$267.15M$264.01M$257.56M$253.54M$242.20M$238.48M$227.40M$226.21M$226.34M$216.79M$209.78M$197.71M$189.16M$172.12M$177.94M$182.91M$159.89M
Low Forecast$372.64M$370.19M$364.58M$356.77M$339.04M$345.61M$341.73M$334.87M$268.82M$289.39M$284.90M$279.48M$271.94M$267.15M$249.51M$243.42M$239.61M$242.20M$238.48M$227.40M$226.21M$226.34M$216.79M$209.78M$197.71M$189.16M$172.12M$177.94M$182.91M$159.89M
# Analysts22221114733363334444333313889127
Surprise %------------1.01%1.01%1.01%1.01%1.00%0.99%0.99%1.00%0.99%0.96%1.01%0.98%0.99%1.03%1.07%1.07%1.04%1.06%

Addus HomeCare's average Quarter revenue forecast for Mar 24 based on 3 analysts is $279.49M, with a low forecast of $279.48M, and a high forecast of $279.49M. ADUS's average Quarter revenue forecast represents a 1.13% increase compared to the company's last Quarter revenue of $276.35M (Dec 23).

Addus HomeCare EBITDA Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts22221114733363334444333313889127
EBITDA------------$33.02M$27.04M$24.92M$22.05M$24.30M$20.96M$20.50M$17.09M$23.44M$20.80M$20.67M$15.79M$14.94M$15.65M$12.70M$13.88M$17.15M$10.25M
Avg Forecast$32.80M$32.58M$32.09M$31.40M$29.84M$30.42M$30.08M$29.47M$24.36M$24.80M$24.41M$20.41M$23.52M$22.89M$21.96M$18.55M$24.38M$20.88M$20.56M$16.87M$19.50M$19.52M$18.69M$15.79M$17.05M$16.31M$14.84M$10.80M$15.77M$13.79M
High Forecast$33.78M$33.56M$33.05M$32.34M$30.74M$31.33M$30.98M$30.36M$25.32M$24.81M$24.41M$24.49M$23.71M$22.89M$22.62M$22.26M$29.25M$20.88M$20.56M$20.24M$19.50M$19.52M$18.69M$18.95M$17.05M$16.31M$14.84M$12.96M$15.77M$13.79M
Low Forecast$31.93M$31.72M$31.24M$30.57M$29.05M$29.61M$29.28M$28.69M$23.03M$24.79M$24.41M$16.33M$23.30M$22.89M$21.38M$14.84M$19.50M$20.88M$20.56M$13.49M$19.50M$19.52M$18.69M$12.63M$17.05M$16.31M$14.84M$8.64M$15.77M$13.79M
Surprise %------------1.40%1.18%1.13%1.19%1.00%1.00%1.00%1.01%1.20%1.07%1.11%1.00%0.88%0.96%0.86%1.29%1.09%0.74%

3 analysts predict ADUS's average Quarter EBITDA for Mar 24 to be $20.41M, with a high of $24.49M and a low of $16.33M. This is -38.19% lower than Addus HomeCare's previous annual EBITDA (Dec 23) of $33.02M.

Addus HomeCare Net Income Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts22221114733363334444333313889127
Net Income------------$19.58M$15.41M$14.85M$12.68M$14.76M$11.54M$11.25M$8.47M$13.06M$11.58M$11.60M$8.89M$8.45M$9.12M$6.91M$8.66M$9.99M$4.87M
Avg Forecast$32.05M$30.01M$29.73M$26.34M$29.54M$27.50M$27.60M$25.17M$24.70M$23.43M$22.17M$10.11M$21.40M$19.77M$18.44M$9.19M$13.58M$15.20M$14.90M$8.36M$14.99M$14.60M$14.33M$8.89M$12.13M$10.63M$7.96M$6.73M$10.87M$9.35M
High Forecast$33.30M$31.18M$30.89M$27.37M$30.69M$28.57M$28.67M$26.16M$25.78M$23.70M$23.34M$12.14M$21.77M$19.77M$19.16M$11.03M$16.30M$15.20M$14.90M$10.03M$14.99M$14.60M$14.33M$10.67M$12.13M$10.63M$7.96M$8.08M$10.87M$9.35M
Low Forecast$30.95M$28.98M$28.70M$25.43M$28.52M$26.55M$26.64M$24.30M$23.08M$23.16M$20.99M$8.09M$20.66M$19.77M$17.80M$7.36M$10.87M$15.20M$14.90M$6.69M$14.99M$14.60M$14.33M$7.12M$12.13M$10.63M$7.96M$5.39M$10.87M$9.35M
Surprise %------------0.91%0.78%0.81%1.38%1.09%0.76%0.76%1.01%0.87%0.79%0.81%1.00%0.70%0.86%0.87%1.29%0.92%0.52%

Addus HomeCare's average Quarter net income forecast for Mar 24 is $10.11M, with a range of $8.09M to $12.14M. ADUS's average Quarter net income forecast represents a -48.34% decrease compared to the company's last Quarter net income of $19.58M (Dec 23).

Addus HomeCare SG&A Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts22221114733363334444333313889127
SG&A------------$60.77M$60.27M$57.40M$56.36M$54.47M$54.23M$55.09M$53.15M$49.54M$46.28M$48.17M$45.43M$44.21M$40.73M$42.45M$45.17M$41.69M$38.71M
Avg Forecast$83.74M$83.19M$81.93M$80.17M$76.19M$77.66M$76.79M$75.25M$62.19M$63.32M$62.32M$63.47M$60.04M$58.44M$56.07M$57.70M$51.53M$52.98M$52.17M$52.45M$49.49M$49.51M$47.42M$45.43M$43.25M$41.38M$37.65M$35.14M$40.01M$34.98M
High Forecast$86.25M$85.69M$84.39M$82.58M$78.48M$80.00M$79.10M$77.51M$64.64M$63.34M$62.32M$76.16M$60.54M$58.44M$57.75M$69.24M$61.84M$52.98M$52.17M$62.94M$49.49M$49.51M$47.42M$54.51M$43.25M$41.38M$37.65M$42.16M$40.01M$34.98M
Low Forecast$81.52M$80.98M$79.75M$78.05M$74.17M$75.60M$74.76M$73.25M$58.81M$63.31M$62.32M$50.77M$59.49M$58.44M$54.58M$46.16M$41.22M$52.98M$52.17M$41.96M$49.49M$49.51M$47.42M$36.34M$43.25M$41.38M$37.65M$28.11M$40.01M$34.98M
Surprise %------------1.01%1.03%1.02%0.98%1.06%1.02%1.06%1.01%1.00%0.93%1.02%1.00%1.02%0.98%1.13%1.29%1.04%1.11%

Addus HomeCare's average Quarter SG&A projection for Mar 24 is $63.47M, based on 3 Wall Street analysts, with a range of $50.77M to $76.16M. The forecast indicates a 4.45% rise compared to ADUS last annual SG&A of $60.77M (Dec 23).

Addus HomeCare EPS Forecast

Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
# Analysts22221114733363334444333313889127
EPS------------$1.20$0.96$0.92$0.79$0.92$0.72$0.70$0.54$0.82$0.73$0.73$0.56$0.53$0.58$0.44$0.56$0.64$0.31
Avg Forecast$1.76$1.64$1.63$1.44$1.62$1.51$1.51$1.38$1.35$1.28$1.21$1.11$1.17$1.08$1.01$0.88$0.95$0.92$0.90$0.75$0.91$0.89$0.87$0.74$0.73$0.64$0.48$0.60$0.66$0.57
High Forecast$1.82$1.71$1.69$1.50$1.68$1.57$1.57$1.43$1.41$1.30$1.28$1.11$1.19$1.08$1.05$0.91$0.99$0.92$0.90$0.75$0.91$0.89$0.87$0.74$0.73$0.64$0.48$0.60$0.66$0.57
Low Forecast$1.70$1.59$1.57$1.39$1.56$1.45$1.46$1.33$1.26$1.27$1.15$1.11$1.13$1.08$0.98$0.84$0.92$0.92$0.90$0.75$0.91$0.89$0.87$0.74$0.73$0.64$0.48$0.60$0.66$0.57
Surprise %------------1.02%0.89%0.91%0.90%0.97%0.78%0.78%0.72%0.90%0.82%0.84%0.76%0.73%0.90%0.91%0.94%0.97%0.55%

According to 3 Wall Street analysts, Addus HomeCare's projected average Quarter EPS for Mar 24 is $1.11, with a low estimate of $1.11 and a high estimate of $1.11. This represents a -7.40% decrease compared to ADUS previous annual EPS of $1.20 (Dec 23).

Addus HomeCare Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
SEMSelect Medical$19.12$40.00109.21%Buy
ACHCAcadia Healthcare Company$39.64$81.50105.60%Buy
AMEDAmedisys$85.37$143.3867.95%Hold
INNVInnovAge$4.08$6.8066.67%Hold
SGRYSurgery Partners$21.03$35.0066.43%Buy
UHSUniversal Health Services$182.60$249.6736.73%Hold
PNTGPennant Group$29.21$34.6718.69%Buy
OPCHOption Care Health$23.42$27.3316.70%Buy
EHABEnhabit$8.29$9.5014.60%Hold
ENSGEnsign Group$140.00$159.0013.57%Buy
ADUSAddus HomeCare$130.73$146.2011.83%Buy
EHCEncompass Health$96.94$107.5010.89%Buy

ADUS Forecast FAQ

Is Addus HomeCare a good buy?

Yes, according to 8 Wall Street analysts, Addus HomeCare (ADUS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 87.50% of ADUS's total ratings.

What is ADUS's price target?

Addus HomeCare (ADUS) average price target is $146.2 with a range of $141 to $150, implying a 11.26% from its last price of $131.4. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Addus HomeCare stock go up soon?

According to Wall Street analysts' prediction for ADUS stock, the company can go up by 11.26% (from the last price of $131.4 to the average price target of $146.2), up by 14.16% based on the highest stock price target, and up by 7.31% based on the lowest stock price target.

Can Addus HomeCare stock reach $200?

ADUS's average twelve months analyst stock price target of $146.2 does not support the claim that Addus HomeCare can reach $200 in the near future.

What is Addus HomeCare's current price target trend?

1 Wall Street analyst forecast a $150 price target for Addus HomeCare (ADUS) this month, up 14.16% from its last price of $131.4. Compared to the last 3 and 12 months, the average price target increased by 12.25% and increased by 0.73%, respectively.

What are Addus HomeCare's analysts' financial forecasts?

Addus HomeCare's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $1.4B (high $1.44B, low $1.36B), average EBITDA is $119.81M (high $123.4M, low $116.63M), average net income is $109.8M (high $114.09M, low $106.02M), average SG&A $305.9M (high $315.08M, low $297.78M), and average EPS is $6.01 (high $6.25, low $5.81). ADUS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $1.5B (high $1.55B, low $1.46B), average EBITDA is $128.87M (high $132.74M, low $125.45M), average net income is $118.13M (high $122.74M, low $114.06M), average SG&A $329.03M (high $338.91M, low $320.3M), and average EPS is $6.47 (high $6.72, low $6.25).

Did the ADUS's actual financial results beat the analysts' financial forecasts?

Based on Addus HomeCare's last annual report (Dec 2023), the company's revenue was $1.06B, beating the average analysts forecast of $1.05B by 1.02%. Apple's EBITDA was $106.56M, beating the average prediction of $86.92M by 22.59%. The company's net income was $62.52M, missing the average estimation of $68.8M by -9.13%. Apple's SG&A was $234.79M, beating the average forecast of $232.25M by 1.10%. Lastly, the company's EPS was $3.83, missing the average prediction of $4.14 by -7.49%. In terms of the last quarterly report (Dec 2023), Addus HomeCare's revenue was $276.35M, beating the average analysts' forecast of $274.47M by 0.69%. The company's EBITDA was $33.02M, beating the average prediction of $23.52M by 40.40%. Addus HomeCare's net income was $19.58M, missing the average estimation of $21.4M by -8.51%. The company's SG&A was $60.77M, beating the average forecast of $60.04M by 1.21%. Lastly, the company's EPS was $1.2, beating the average prediction of $1.17 by 2.36%